Pacific Biosciences of California (NASDAQ:PACB) shares are on a 42% nosedive after announcing this morning before market open that Roche has terminated its collaboration …
Investors are running away drom Pacific BioPacific Biosciences of California (NASDAQ:PACB), after the company announced that Roche has terminated their collaboration agreement, whereby Roche …
Analysts are weighing in on biotech companies Pacific Biosciences of California (NASDAQ:PACB) and Osiris Therapeutics, Inc. (NASDAQ:OSIR), as shares of both companies fell sharply today …
